GBA's "2021 Stock Phantasma"

Jefferies upgrades Funko to Buy on confidence in 10%-plus growth 05:07 FNKO Jefferies analyst Stephanie Wissink upgraded Funko to Buy from Hold with a price target of $25, up from $21. The analyst has grown "increasingly confident" in the company's 10%-plus medium term growth profile and its business trajectory after attending last week's 2021 Virtual Licensing Expo event. Wissink sees a favorable backdrop as store traffic returns and says Funko's model is "de-risked" by property, category and geographic concentration. Figures remain the most popular expression for Funko fans, but additional categories continue to co-grow, Wissink tells investors in a research note. Covid "provided space for fans to dig deeper into back stories, lore, and to unearth second and third level characters," which has reinforced the breadth of the company's approach and reinforced its "tight lock on licensing partnerships," says the analyst.

:)
 
Woa This is an aggressive lets look into it-

Adagio Therapeutics initiated with a Buy at Stifel 05:01 ADGI Stifel analyst Stephen Willey initiated coverage of Adagio Therapeutics with a Buy rating and $57 price target. The analyst believes ADG20's value proposition as a low-cost, point-of-care therapeutic that can be easily administered in the outpatient setting while providing "durable, best-in-class neutralization potency" against all Covid-19 and related SARS-like viruses will address many of the biological and logistical constraints which have limited monoclonal antibody therapy utilization rates. Vaccines alone are unlikely to sufficiently address the current Covid pandemic, Willey tells investors in a research note. He believes Adagio's ADG20 is "uniquely differentiated" from other SARS-CoV-2-targeting mAb therapeutics.

YIKES! I'm confused never heard from this company... WTF.

Adagio Therapeutics initiated with a Buy at Jefferies 04:58 ADGI

2nd Possible gummy- ADGI- $32
 
Last edited:
Primoris director buys 10K shares of common stock 19:36 PRIM In a regulatory filing, Primoris disclosed that its board member Terry McCallister bought 10K shares of common stock on August 26th in a total transaction size of $246K.

Spok confirms receipt of letter from Acacia Research, will evaluate offer 19:16 SPOK, ACTG Spok Holding (SPOK) "announced that it has received a letter, and is aware of a public announcement, from Acacia Research Corporation (ACTG) regarding a proposal to acquire all of the outstanding shares of common stock of Spok for $10.75 per share in cash. Spok's Board of Directors intends to evaluate the letter in consultation with its regular independent financial and legal advisors. At this time, Spok shareholders are not required to take any action."

SPOK- $7.35////

Just checked pre market-- $9.27
 
Last edited:
Ok I'm not going crazy ADGI just came public this month. And it went crazy.
Aug 7 @$21----> 32.60

Adagio Therapeutics stock set to begin trading after IPO values COVID-drug firm at $1.9B>>>>>

Dive Insight:
Adagio is well behind other antibody drug developers for COVID-19. But the company claims a few advantages it hopes will help it play a role in this pandemic and any future ones, too.

ADG20 binds to a different target than rival drugs from Regeneron, Vir and Eli Lilly, a difference Adagio says could better neutralize a variety of coronaviruses as well as variants. The drug is given through a single intramuscular injection, rather than via multiple shots or infusions at a healthcare facility. Early testing also showed the drug may last longer than its competitors.

Those factors would give Adagio an edge if ADG20 is proven safe and effective in the two ongoing trials. Lilly's two COVID-19 antibody drugs have proven less effective against certain circulating variants, causing one to be pulled from the market and the U.S. to stop distribution of another. Regeneron and Vir's treatments haven't had those problems, but both face logistical challenges that have slowed the overall uptake of COVID-19 antibody treatments.

Far Behind REGN but 1 shot vs 4.>
 
These guys are pretty petrol based with their pipes and such but...

Description
Primoris Services Corporation, a specialty contractor company, provides a range of construction, fabrication, maintenance, replacement, and engineering services in the United States and Canada. It operates in five segments: Power, Industrial, and Engineering; Pipeline and Underground; Utilities and Distribution; Transmission and Distribution; and Civil. The Power, Industrial, and Engineering segment offers engineering, procurement, construction, retrofit, upgrade, repair, outage, and maintenance services for entities in the petroleum and petrochemical industries, as well as traditional and renewable power generators. The Pipeline and Underground segment provides a range of services comprising pipeline construction, maintenance, facility, and integrity services; installation of compressor and pump stations; and metering facilities for entities in the petroleum and petrochemical industries, as well as gas, water,<------- and sewer utilities.

So it's a play on Biden's rebuild plan AND maybe those lead pipes in the drinking water!
w/ Insider buy.
 
SelectQuote, Inc. (SLQT)- @$9.20

8.89+0.54 (+6.47%)
At close: August 30 4:00PM EDT
9.21+0.32 (3.60%)<---------------
Pre-Market:

I always think this is stock market quotes-- It's insurance.

Description
Founded in 1985, SelectQuote (NYSE: SLQT) provides solutions that help consumers protect their most valuable assets: their families, health and property. The company pioneered the direct-to-consumer model of providing unbiased comparisons from multiple, highly-rated insurance companies allowing consumers to choose the policy and terms that best meet their unique needs.
 
Description
B.O.S. Better Online Solutions Ltd. provides intelligent robotics, radio frequency identification (RFID), and supply chain solutions for enterprises worldwide. The Intelligent Robotics Division provides In-Mould Labelling, a robotic system that is used for manufacturing of containers by blow molding, injection molding, or thermoforming processes through the use of paper or plastic labels; and Downstream Automation, a process starts after the injection mould process ends through the packing of the mould. The RFID Division offers hardware products, such as thermal and barcode printers; RFID and barcode scanners and readers; wireless, mobile, and forklift terminals; wireless infrastructure; active and passive RFID tags; ribbons, labels, and tags; and RFID systems for libraries. It also develops Warehouse Management System, a data collection solution for logistics management in logistic centers and warehouses; RFID systems for libraries; RFID-based systems for tracking inventory in a produce packing house; automatic systems for industrial packing lines; automatic systems to track the production line; and automatic systems to identify and track vehicles for transportation-related settings.
 
stonedinvestor said:
Ok so what is High-temp? that sounds hot not cold....

!
More...
"Tepid" maybe?
At least she was honest right?
Lost a gillion in market-cap, but kudos for being forthright.
(referring to ZM conference call for readers that missed yesterday)
****note to aspiring young CEO's>>>>to the greatest extent possible, avoid using the words "tepid" and "growth" in the same sentence.

++++++++++++++++++++++++++++++++++++++

DBI
6 analysts $0.24>>>>> actual $0.56
$751M rev expected>>>> $817M

sell the news, buy back in later at $14
 
Vir Biotechnology, Inc. (VIR)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD

51.16+1.30 (+2.61%)
As of 9:55A

GoDaddy Inc. (GDDY)
NYSE - Nasdaq Real Time Price. Currency in USD

$73.91+0.47 (+0.64%)
As of 9:55A

Adagio Therapeutics, Inc. (ADGI)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD

$33.95+1.60 (+4.96%)
As of 9:55
 
So my wife has pulled off two ticks off her this summer and NOW she feels the Lyme. No rash.
Sweating through the sheets and muscle pain.
We are off to a Doc In The Box as she calls it... 1/2 hr drive... Great way to end this shitty ass summer of wetness.

This Adagio looks super promising but it has come so far... I just can't. Normally that's the one I would of went with....

I'll be back after lunch. ~stoney
 
You must log in or register to reply here.
Back
Top